Pharmaceutical Preparation
Simple SummaryContent extracted from patent full text and abstract with AI.
This patent describes a pharmaceutical composition for treating infections that contains aminoglycoside antibiotics such as tobramycin and gentamicin, essential oils or their components, along with other additives. By combining conventional antibiotics with natural essential oils, the composition aims to enhance treatment effectiveness against infectious diseases.
Use CasesContent extracted from patent full text and abstract with AI.
- Treatment of bacterial infections in humans, especially those resistant to standard antibiotics
- Use in hospital settings to manage infectious disease outbreaks
- Potential application in veterinary medicine for treating animal infections
- Development of topical preparations (creams or ointments) for skin infections
- Inhalation or oral formulations for respiratory or systemic infections
BenefitsContent extracted from patent full text and abstract with AI.
- Potentially increased effectiveness of antibiotics due to synergistic effect with essential oils
- Could help address antibiotic resistance issues by introducing new treatment combinations
- May reduce necessary antibiotic dosage, lowering risk of side effects
- Offers a more versatile approach to infection treatment by combining synthetic and natural agents
- Possible improved safety profile and tolerability due to presence of essential oils
Technical Classifications (CPCs)
Main Classifications
Chemistry & Materials Science
Health, Food & Consumer Tech
Sub Classifications
Biochemistry, Beer & Spirits
Medical & Vet Science
CPC Codes
Inventors & Applicants
Inventors
N/A
Applicants
Charite Univ Institut Fuer Mikrobiologie und Infektionsimmunologie
Freie Univ Berlin Institut Fuer Pharmazie
Hofmann & Sommer Gmbh und Co Kg Chemisch Pharmazeutische Fabrik
Patent Abstract
Pharmazeutische Zubereitung zur Behandlung von Infektionen, dadurch gekennzeichnet, dass als Wirkstoffe Aminoglykosidantibiotika wie Tobramycin und Gentamicin und ätherische Öle oder deren Inhaltsstoffe enthalten sind sowie weitere Zusatzstoffe.
Key Information
Publication No.
DE202019003621U1
Family ID
70416855
Publication Date
2020-03-23
Application No.
DE202019003621U
Application Date
2019-08-30
Priority Date
2019-08-30
Granted
Yes (1/2)
Possible Cooperation
For further information please contact the transfer office.